Carl G. Figdor

57.8k total citations · 11 hit papers
528 papers, 46.9k citations indexed

About

Carl G. Figdor is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Carl G. Figdor has authored 528 papers receiving a total of 46.9k indexed citations (citations by other indexed papers that have themselves been cited), including 366 papers in Immunology, 164 papers in Molecular Biology and 126 papers in Oncology. Recurrent topics in Carl G. Figdor's work include Immunotherapy and Immune Responses (298 papers), T-cell and B-cell Immunology (139 papers) and Immune Cell Function and Interaction (104 papers). Carl G. Figdor is often cited by papers focused on Immunotherapy and Immune Responses (298 papers), T-cell and B-cell Immunology (139 papers) and Immune Cell Function and Interaction (104 papers). Carl G. Figdor collaborates with scholars based in Netherlands, United States and Germany. Carl G. Figdor's co-authors include Gosse J. Adema, Yvette van Kooyk, I. Jolanda M. de Vries, J E de Vries, Ruurd Torensma, René de Waal Malefyt, J S Abrams, Alessandra Cambi, Sandra J. van Vliet and Paul J. Tacken and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Carl G. Figdor

528 papers receiving 46.0k citations

Hit Papers

Interleukin 10(IL-10) inh... 1991 2026 2002 2014 1991 2000 1991 2000 2013 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
    1991 3.2k citations Carl G. Figdor et al. profile →
  2. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells
    2000 1.9k citations Ruurd Torensma, Carl G. Figdor et al. profile →
  3. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    1991 1.7k citations John B.A.G. Haanen, Carl G. Figdor et al. profile →
  4. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses
    2000 1.4k citations Ruurd Torensma, Gosse J. Adema et al. profile →
  5. Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force
    2013 1.0k citations Carl G. Figdor, Peter Friedl et al. The Journal of Cell Biology profile →
  6. Dendritic cell immunotherapy: mapping the way
    2004 778 citations Carl G. Figdor, I. Jolanda M. de Vries et al. profile →
  7. C-type lectin receptors on dendritic cells and langerhans cells
    2002 667 citations Carl G. Figdor, Gosse J. Adema et al. profile →
  8. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
    2005 666 citations I. Jolanda M. de Vries, W. Joost Lesterhuis et al. profile →
  9. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting
    2007 615 citations Paul J. Tacken, I. Jolanda M. de Vries et al. profile →
  10. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.
    1993 553 citations Carl G. Figdor et al. profile →
  11. The Dendritic Cell-Specific Adhesion Receptor DC-SIGN Internalizes Antigen for Presentation to T Cells
    2002 514 citations Carl G. Figdor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl G. Figdor Netherlands 112 27.4k 14.1k 10.5k 5.2k 4.1k 528 46.9k
Ulrich H. von Andrian United States 109 26.1k 1.0× 9.8k 0.7× 7.6k 0.7× 7.4k 1.4× 2.0k 0.5× 256 42.9k
Michael L. Dustin United States 115 31.7k 1.2× 13.2k 0.9× 7.7k 0.7× 11.9k 2.3× 2.2k 0.5× 391 52.0k
Andrew D. Luster United States 120 29.2k 1.1× 10.8k 0.8× 14.2k 1.4× 4.6k 0.9× 1000 0.2× 342 51.2k
Ronald N. Germain United States 114 30.5k 1.1× 12.1k 0.9× 6.4k 0.6× 1.8k 0.3× 1.4k 0.3× 348 42.8k
Siamon Gordon United Kingdom 133 41.2k 1.5× 22.0k 1.6× 6.7k 0.6× 3.4k 0.6× 2.1k 0.5× 455 78.1k
Nico van Rooijen Netherlands 146 38.1k 1.4× 21.4k 1.5× 10.0k 0.9× 2.7k 0.5× 2.0k 0.5× 838 80.5k
Jo Van Damme Belgium 108 16.7k 0.6× 12.7k 0.9× 13.7k 1.3× 4.2k 0.8× 1.0k 0.3× 547 41.8k
Klaus Ley United States 122 26.9k 1.0× 16.3k 1.2× 6.6k 0.6× 13.2k 2.5× 3.1k 0.8× 457 55.9k
Hideo Yagita∥ Japan 128 43.5k 1.6× 18.2k 1.3× 21.7k 2.1× 3.3k 0.6× 1.1k 0.3× 912 67.3k
Ira Mellman United States 109 23.7k 0.9× 24.0k 1.7× 14.1k 1.3× 1.6k 0.3× 2.6k 0.6× 268 53.8k

Countries citing papers authored by Carl G. Figdor

Since Specialization
Citations

This map shows the geographic impact of Carl G. Figdor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl G. Figdor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl G. Figdor more than expected).

Fields of papers citing papers by Carl G. Figdor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl G. Figdor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl G. Figdor. The network helps show where Carl G. Figdor may publish in the future.

Co-authorship network of co-authors of Carl G. Figdor

This figure shows the co-authorship network connecting the top 25 collaborators of Carl G. Figdor. A scholar is included among the top collaborators of Carl G. Figdor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl G. Figdor. Carl G. Figdor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elsas, Marit J van, Alexander Bartels, Carl G. Figdor, et al.. (2022). Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody. International Journal of Molecular Sciences. 23(15). 8707–8707. 4 indexed citations
2.
Slaats, Jeroen, Cindy E. Dieteren, Esther Wagena, et al.. (2021). Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery. Cancer Immunology Research. 9(8). 926–938. 6 indexed citations
3.
Creemers, Jeroen H. A., W. Joost Lesterhuis, Niven Mehra, et al.. (2021). A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery. Journal for ImmunoTherapy of Cancer. 9(5). e002032–e002032. 15 indexed citations
4.
Khalil, Antoine, Olga Ilina, Angela Vasaturo, et al.. (2020). Collective invasion induced by an autocrine purinergic loop through connexin-43 hemichannels. The Journal of Cell Biology. 219(10). 28 indexed citations
5.
Bakdash, Ghaith, Sonja I. Buschow, Mark A.J. Gorris, et al.. (2016). Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines. Cancer Research. 76(15). 4332–4346. 90 indexed citations
6.
Vasaturo, Angela, Altuna Halilović, Kalijn F. Bol, et al.. (2016). T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines. Cancer Research. 76(12). 3496–3506. 28 indexed citations
7.
Berk, Lieke C. J. van den, Bas Jansen, Stuart G. Snowden, et al.. (2014). Cord Blood Mesenchymal Stem Cells Suppress DC-T Cell Proliferation via Prostaglandin B2. Stem Cells and Development. 23(14). 1582–1593. 14 indexed citations
8.
Tel, Jurjen, Erik H.J.G. Aarntzen, Tetsuro Baba, et al.. (2013). Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients. Cancer Research. 73(3). 1063–1075. 289 indexed citations
9.
Aarntzen, Erik H.J.G., Mangala Srinivas, F. Bonetto, et al.. (2013). Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells. Clinical Cancer Research. 19(6). 1525–1533. 49 indexed citations
10.
Aarntzen, Erik H.J.G., I. Jolanda M. de Vries, W. Joost Lesterhuis, et al.. (2012). Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination. Cancer Research. 73(1). 19–29. 131 indexed citations
11.
Aarntzen, Erik H.J.G., Kalijn F. Bol, Gerty Schreibelt, et al.. (2012). Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell–Based Vaccination in Metastatic Melanoma. Cancer Research. 72(23). 6102–6110. 42 indexed citations
12.
Aarntzen, Erik H.J.G., Gerty Schreibelt, Kalijn F. Bol, et al.. (2012). Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients. Clinical Cancer Research. 18(19). 5460–5470. 80 indexed citations
13.
Lesterhuis, W. Joost, I. Jolanda M. de Vries, Gerty Schreibelt, et al.. (2011). Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients. Clinical Cancer Research. 17(17). 5725–5735. 138 indexed citations
14.
Hegmans, Joost P., Joris D. Veltman, Margaretha Lambers, et al.. (2010). Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma. American Journal of Respiratory and Critical Care Medicine. 181(12). 1383–1390. 120 indexed citations
15.
Helden, Suzanne F. G. van, et al.. (2008). PGE2-mediated podosome loss in dendritic cells is dependent on actomyosin contraction downstream of the RhoA–Rho-kinase axis. Journal of Cell Science. 121(7). 1096–1106. 73 indexed citations
16.
Nierkens, Stefan, Martijn H. den Brok, Roger P.M. Sutmuller, et al.. (2008). In vivo Colocalization of Antigen and CpG within Dendritic Cells Is Associated with the Efficacy of Cancer Immunotherapy. Cancer Research. 68(13). 5390–5396. 47 indexed citations
17.
Sutmuller, Roger P.M., Stefan Nierkens, Erik Bennink, et al.. (2006). Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. British Journal of Cancer. 95(7). 896–905. 228 indexed citations
18.
Tacken, Paul J., I. Jolanda M. de Vries, Karlijn Gijzen, et al.. (2005). Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody. Blood. 106(4). 1278–1285. 219 indexed citations
19.
Lindhout, Ernst, Joost L. M. Vissers, Carl G. Figdor, & Gosse J. Adema. (1999). Chemokines and lymphocyte migration. Radboud Repository (Radboud University). 7. 147–152. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich H. von Andrian Breakdown of academic impact, for papers by Michael L. Dustin Breakdown of academic impact, for papers by Andrew D. Luster Breakdown of academic impact, for papers by Ronald N. Germain Breakdown of academic impact, for papers by Siamon Gordon Breakdown of academic impact, for papers by Nico van Rooijen Breakdown of academic impact, for papers by Jo Van Damme Breakdown of academic impact, for papers by Klaus Ley Breakdown of academic impact, for papers by Hideo Yagita∥ Breakdown of academic impact, for papers by Ira Mellman
Rankless by CCL
2026